DrugPatentWatch Database Preview
Cppi Cv Company Profile
What is the competitive landscape for CPPI CV, and what generic alternatives to CPPI CV drugs are available?
CPPI CV has one approved drug.
There are three US patents protecting CPPI CV drugs.
There are seventy-three patent family members on CPPI CV drugs in forty-one countries and twenty-four supplementary protection certificates in thirteen countries.
Summary for Cppi Cv
| International Patents: | 73 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Cppi Cv
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cppi Cv | SUTENT | sunitinib malate | CAPSULE;ORAL | 021938-004 | Mar 31, 2009 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Cppi Cv | SUTENT | sunitinib malate | CAPSULE;ORAL | 021938-003 | Jan 26, 2006 | RX | Yes | Yes | 7,125,905*PED | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Cppi Cv | SUTENT | sunitinib malate | CAPSULE;ORAL | 021938-004 | Mar 31, 2009 | RX | Yes | No | 6,573,293*PED | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Cppi Cv | SUTENT | sunitinib malate | CAPSULE;ORAL | 021938-003 | Jan 26, 2006 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Cppi Cv | SUTENT | sunitinib malate | CAPSULE;ORAL | 021938-004 | Mar 31, 2009 | RX | Yes | No | 7,125,905*PED | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for CPPI CV drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsules | 12.5 mg, 25 mg, 37.5 mg and 50 mg | ➤ Subscribe | 2010-01-26 |
International Patents for Cppi Cv Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Serbia | 50444 | ➤ Try a Free Trial |
| Eurasian Patent Organization | 200200862 | ➤ Try a Free Trial |
| Japan | 3663382 | ➤ Try a Free Trial |
| Costa Rica | 20120007 | ➤ Try a Free Trial |
| Australia | 3436301 | ➤ Try a Free Trial |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for Cppi Cv Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1255752 | 312 | Finland | ➤ Try a Free Trial | |
| 1255752 | 10C0003 | France | ➤ Try a Free Trial | PRODUCT NAME: TOCERAMIB ET OPTIONELLEMENT SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, ET EN PARTICULIER LE PHOSPHATE DE TOCERANIB; REGISTRATION NO/DATE IN FRANCE: EU/2/09/100/001 DU 20090923; REGISTRATION NO/DATE AT EEC: EU/2/09/100/001 DU 20090923 |
| 1255752 | PA2010002 | Lithuania | ➤ Try a Free Trial | PRODUCT NAME: TOCERANIBUM; REGISTRATION NO/DATE: EU/2/09/100/001, 2009 09 23 EU/2/09/100/002, 2009 09 23 EU/2/09/100/003 20090923 |
| 1255752 | 378 | Finland | ➤ Try a Free Trial | |
| 1255752 | 91657 | Luxembourg | ➤ Try a Free Trial | 91657, EXPIRES: 20240923 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
